ZEB1 expression is associated with the PTEN loss and TMPRSS2 ERG fusion immune evasion phenotype in prostate cancer (2021)
- Authors:
- USP affiliated authors: SAGGIORO, FABIANO PINTO - SVOI ; SQUIRE, JEREMY ANDREW - FMRP ; SOUZA, LUIZ PAULO CHAVES DE - FMRP ; COSTA, ANDRÉ LUIZ CALIARI - FMRP
- Unidades: SVOI; FMRP
- DOI: 10.1158/1538-7445.AM2021-1818
- Subjects: PRÓSTATA; NEOPLASIAS; MUTAÇÃO GENÉTICA; IMUNOHISTOQUÍMICA
- Language: Inglês
- Imprenta:
- Publisher place: Philadelphia
- Date published: 2021
- Source:
- Título: Cancer Research
- ISSN: 0008-5472
- Volume/Número/Paginação/Ano: v. 81, suppl. 13, res. 1818, 2021
- Conference titles: Proceedings of the American Association for Cancer Research Annual Meeting
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
SOUZA, Luiz Paulo Chaves et al. ZEB1 expression is associated with the PTEN loss and TMPRSS2 ERG fusion immune evasion phenotype in prostate cancer. Cancer Research. Philadelphia: , Universidade de São Paulo. Disponível em: https://doi.org/10.1158/1538-7445.AM2021-1818. Acesso em: 03 nov. 2024. , 2021 -
APA
Souza, L. P. C., Costa, A. L. C., Melo, C. M., Saggioro, F. P., & Squire, J. A. (2021). ZEB1 expression is associated with the PTEN loss and TMPRSS2 ERG fusion immune evasion phenotype in prostate cancer. Cancer Research. Philadelphia: , Universidade de São Paulo. doi:10.1158/1538-7445.AM2021-1818 -
NLM
Souza LPC, Costa ALC, Melo CM, Saggioro FP, Squire JA. ZEB1 expression is associated with the PTEN loss and TMPRSS2 ERG fusion immune evasion phenotype in prostate cancer [Internet]. Cancer Research. 2021 ; 81[citado 2024 nov. 03 ] Available from: https://doi.org/10.1158/1538-7445.AM2021-1818 -
Vancouver
Souza LPC, Costa ALC, Melo CM, Saggioro FP, Squire JA. ZEB1 expression is associated with the PTEN loss and TMPRSS2 ERG fusion immune evasion phenotype in prostate cancer [Internet]. Cancer Research. 2021 ; 81[citado 2024 nov. 03 ] Available from: https://doi.org/10.1158/1538-7445.AM2021-1818 - Analysis of the relationships between ZEB1, PTEN loss, TMPRSS2-ERG fusion and immune response biomarkers in Prostate Cancer
- PTEN loss associates with STAT1/3 expression and intra-tumoral CD8+ density in prostate cancer
- Epithelial–mesenchymal transition signaling and prostate cancer stem cells: emerging biomarkers and opportunities for precision therapeutics
- Trannscriptomics and immune response in human cancer
- A expressão dos marcadores de transição epitélio-mesenquimal SNAI1 e o ZEB1 resulta em alterações transcricionais para promover progressão tumoral e evasão imune no câncer de próstata
- Identificação de vias de sinalização imunossupressoras associada à infecção por SARS-CoV-2 em células epiteliais nasofaríngeas de pacientes do sexo masculino e feminino
- TCGA analysis identifies distinct genomic features of oncogenic progression and outcome associated with hemizygous PTEN loss tumors
- Quantitative assessment of PTEN loss (qPTEN) is strongly associated with biochemical recurrence and may improve treatment decisions after surgery
- Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study
- Digital expression profiling identifies RUNX2, CDC5L, MDM2, RECQL4, and CDK4 as potential predictive biomarkers for neo-adjuvant chemotherapy response in paediatric osteosarcoma
Informações sobre o DOI: 10.1158/1538-7445.AM2021-1818 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
